EPIX
ESSA Pharma
EPIX
EPIX
Delisted
EPIX was delisted on the 8th of October, 2025.
33 hedge funds and large institutions have $297M invested in ESSA Pharma in 2024 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 10 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
9.06% less ownership
Funds ownership: 88.26% → 79.2% (-9.1%)
50% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 10
Holders
33
Holding in Top 10
1
Calls
$492K
Puts
$277K
Top Buyers
| 1 | +$4.71M | |
| 2 | +$3.77M | |
| 3 | +$3.13M | |
| 4 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
+$2.14M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$728K |
Top Sellers
| 1 | -$35.6M | |
| 2 | -$6.27M | |
| 3 | -$2.39M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$1.93M |
| 5 |
D.E. Shaw & Co
New York
|
-$1.14M |